Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy; A Real Life Experience

Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy; A Real Life Experience

INTRODUCTION[|]The aim of this study was to evaluate the 2-year outcomes of intravitreal ranibizumab (IVR) therapy in combination with photodynamic therapy (PDT) in patients with polypoidal choroidal vasculopathy (PCV).[¤]METHODS[|]Patients with PCV who presented at the clinic between January 2013 a...

Full description

Bibliographic Details
Main Authors: Sibel Ahmet, Okkes Baz, Gokhan Demir, Ali Demircan, Zeynep Alkin, Abdullah Ozkaya, Alperen Koc, Muhittin Taskapili
Format: Article
Language:English
Published: KARE Publishing 2017-12-01
Series:Beyoglu Eye Journal
Subjects:
combined therapy
polypoidal choroidal vasculopathy
ranibizumab.
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-14633

Similar Items

Similar Items